Special considerations for research with pharmacologic agents
As physical medicine and rehabilitation becomes more and more complicated, the medical rehabilitation research teams are often bewildered by the sweeping changes occurring in the application of therapeutic drugs for rehabilitation. Society, through the instrument of governmental regulations, dictate...
Gespeichert in:
| Veröffentlicht in: | American journal of physical medicine & rehabilitation 1991-04, Vol.70 (2), p.101-106 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 106 |
|---|---|
| container_issue | 2 |
| container_start_page | 101 |
| container_title | American journal of physical medicine & rehabilitation |
| container_volume | 70 |
| creator | Basmajian, J V |
| description | As physical medicine and rehabilitation becomes more and more complicated, the medical rehabilitation research teams are often bewildered by the sweeping changes occurring in the application of therapeutic drugs for rehabilitation. Society, through the instrument of governmental regulations, dictates that all new treatments must be efficacious before "release." |
| doi_str_mv | 10.1097/00002060-199104000-00010 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00002060_199104000_00010</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2009156</sourcerecordid><originalsourceid>FETCH-LOGICAL-c199t-10ed280534056917857c2c2a5458730d40f27cfb08bb7f4294f985d17637a05e3</originalsourceid><addsrcrecordid>eNo9kM1KxDAQgHNQ1nX1EYS8QHSSJk1y8CCLf7DgQT2HNE22kXZbkor49kZ33YFhfuAbhg8hTOGagpY3UIJBDYRqTYGXiZSkcIKWoDQnmlJxhs5z_ihroSu5QAsGoKmol-j2dfIu2h67cZdj65OdY-lwGBNOPnubXIe_4tzhqbNpsG7sx2102G79bs4X6DTYPvvLQ12h94f7t_UT2bw8Pq_vNsSVn2ZCwbdMgag4iFpTqYR0zDEruFCygpZDYNKFBlTTyMCZ5kEr0VJZV9KC8NUKqf1dl8ackw9mSnGw6dtQML8SzL8Ec5Rg_iQU9GqPTp_N4NsjeDBQ_QC_-Fhr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Special considerations for research with pharmacologic agents</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Basmajian, J V</creator><creatorcontrib>Basmajian, J V</creatorcontrib><description>As physical medicine and rehabilitation becomes more and more complicated, the medical rehabilitation research teams are often bewildered by the sweeping changes occurring in the application of therapeutic drugs for rehabilitation. Society, through the instrument of governmental regulations, dictates that all new treatments must be efficacious before "release."</description><identifier>ISSN: 0894-9115</identifier><identifier>DOI: 10.1097/00002060-199104000-00010</identifier><identifier>PMID: 2009156</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Dantrolene - adverse effects ; Dantrolene - therapeutic use ; Drug Evaluation - methods ; Humans ; Muscle Spasticity - drug therapy ; Pharmacology ; Placebos ; Research Design - standards ; Risk Factors ; United States ; United States Food and Drug Administration</subject><ispartof>American journal of physical medicine & rehabilitation, 1991-04, Vol.70 (2), p.101-106</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2009156$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Basmajian, J V</creatorcontrib><title>Special considerations for research with pharmacologic agents</title><title>American journal of physical medicine & rehabilitation</title><addtitle>Am J Phys Med Rehabil</addtitle><description>As physical medicine and rehabilitation becomes more and more complicated, the medical rehabilitation research teams are often bewildered by the sweeping changes occurring in the application of therapeutic drugs for rehabilitation. Society, through the instrument of governmental regulations, dictates that all new treatments must be efficacious before "release."</description><subject>Animals</subject><subject>Dantrolene - adverse effects</subject><subject>Dantrolene - therapeutic use</subject><subject>Drug Evaluation - methods</subject><subject>Humans</subject><subject>Muscle Spasticity - drug therapy</subject><subject>Pharmacology</subject><subject>Placebos</subject><subject>Research Design - standards</subject><subject>Risk Factors</subject><subject>United States</subject><subject>United States Food and Drug Administration</subject><issn>0894-9115</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kM1KxDAQgHNQ1nX1EYS8QHSSJk1y8CCLf7DgQT2HNE22kXZbkor49kZ33YFhfuAbhg8hTOGagpY3UIJBDYRqTYGXiZSkcIKWoDQnmlJxhs5z_ihroSu5QAsGoKmol-j2dfIu2h67cZdj65OdY-lwGBNOPnubXIe_4tzhqbNpsG7sx2102G79bs4X6DTYPvvLQ12h94f7t_UT2bw8Pq_vNsSVn2ZCwbdMgag4iFpTqYR0zDEruFCygpZDYNKFBlTTyMCZ5kEr0VJZV9KC8NUKqf1dl8ackw9mSnGw6dtQML8SzL8Ec5Rg_iQU9GqPTp_N4NsjeDBQ_QC_-Fhr</recordid><startdate>199104</startdate><enddate>199104</enddate><creator>Basmajian, J V</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199104</creationdate><title>Special considerations for research with pharmacologic agents</title><author>Basmajian, J V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c199t-10ed280534056917857c2c2a5458730d40f27cfb08bb7f4294f985d17637a05e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Animals</topic><topic>Dantrolene - adverse effects</topic><topic>Dantrolene - therapeutic use</topic><topic>Drug Evaluation - methods</topic><topic>Humans</topic><topic>Muscle Spasticity - drug therapy</topic><topic>Pharmacology</topic><topic>Placebos</topic><topic>Research Design - standards</topic><topic>Risk Factors</topic><topic>United States</topic><topic>United States Food and Drug Administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Basmajian, J V</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>American journal of physical medicine & rehabilitation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Basmajian, J V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Special considerations for research with pharmacologic agents</atitle><jtitle>American journal of physical medicine & rehabilitation</jtitle><addtitle>Am J Phys Med Rehabil</addtitle><date>1991-04</date><risdate>1991</risdate><volume>70</volume><issue>2</issue><spage>101</spage><epage>106</epage><pages>101-106</pages><issn>0894-9115</issn><abstract>As physical medicine and rehabilitation becomes more and more complicated, the medical rehabilitation research teams are often bewildered by the sweeping changes occurring in the application of therapeutic drugs for rehabilitation. Society, through the instrument of governmental regulations, dictates that all new treatments must be efficacious before "release."</abstract><cop>United States</cop><pmid>2009156</pmid><doi>10.1097/00002060-199104000-00010</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0894-9115 |
| ispartof | American journal of physical medicine & rehabilitation, 1991-04, Vol.70 (2), p.101-106 |
| issn | 0894-9115 |
| language | eng |
| recordid | cdi_crossref_primary_10_1097_00002060_199104000_00010 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Animals Dantrolene - adverse effects Dantrolene - therapeutic use Drug Evaluation - methods Humans Muscle Spasticity - drug therapy Pharmacology Placebos Research Design - standards Risk Factors United States United States Food and Drug Administration |
| title | Special considerations for research with pharmacologic agents |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A23%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Special%20considerations%20for%20research%20with%20pharmacologic%20agents&rft.jtitle=American%20journal%20of%20physical%20medicine%20&%20rehabilitation&rft.au=Basmajian,%20J%20V&rft.date=1991-04&rft.volume=70&rft.issue=2&rft.spage=101&rft.epage=106&rft.pages=101-106&rft.issn=0894-9115&rft_id=info:doi/10.1097/00002060-199104000-00010&rft_dat=%3Cpubmed_cross%3E2009156%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2009156&rfr_iscdi=true |